Who owns ADAGIO THERAPEUTICS INC?
- Ticker: IVVD
- CUSIP Number: 00534a102
Tip: Access positions for across all investors
Analyze quarterly positions in Adagio Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Adagio Therapeutics stock
Who bought or sold ADAGIO THERAPEUTICS INC this quarter?
Fund or Company Name |
Shares Held |
Valued At |
Change in Shares |
As Of |
Actions |
|---|---|---|---|---|---|
| Maverick Capital | 12M | $5.2M | 0% | Dec 2024 |
|
| Mithril II GP | 11M | $5.0M | 100% | Dec 2024 |
|
| Deep Track Capital | 11M | $4.7M | -2% | Dec 2024 |
|
| M28 Capital Management | 9.2M | $4.1M | 0% | Dec 2024 |
|
| FMR | 5.8M | $2.6M | -21% | Dec 2024 |
|
| BlackRock | 4.7M | $2.1M | 2% | Dec 2024 |
|
| Vanguard Group | 4.3M | $1.9M | -1% | Dec 2024 |
|
| Redmile Group | 3.0M | $1.3M | -2% | Dec 2024 |
|
| 683 Capital Management | 3.0M | $1.3M | 0% | Dec 2024 |
|
| Bain Capital Life Sciences Investors | 1.8M | $797k | 0% | Dec 2024 |
|
| Geode Capital Management | 1.6M | $708k | -2% | Dec 2024 |
|
| OrbiMed Advisors | 1.1M | $509k | -34% | Dec 2024 |
|
| State Street Corporation | 1.1M | $508k | 12% | Dec 2024 |
|
| Deutsche Bank Aktiengesellschaft | 874k | $385k | 35% | Dec 2024 |
|
| Duquesne Family Office | 571k | $253k | 0% | Dec 2024 |
|
| Northern Trust | 559k | $248k | -2% | Dec 2024 |
|
| Acadian Asset Management | 506k | $222k | -22% | Dec 2024 |
|
| GSA Capital Partners | 462k | $205k | 100% | Dec 2024 |
|
| UBS Group | 387k | $172k | 638% | Dec 2024 |
|
| Two Sigma Investments | 367k | $163k | 125% | Dec 2024 |
|
| Tang Capital Management | 330k | $146k | 0% | Dec 2024 |
|
| Two Sigma Advisers | 304k | $135k | 1276% | Dec 2024 |
|
| Bridgeway Capital Management | 303k | $134k | -2% | Dec 2024 |
|
| Jpmorgan Chase & Co | 257k | $114k | 644% | Dec 2024 |
|
| Goldman Sachs Group | 250k | $111k | 51% | Dec 2024 |
|
| Morgan Stanley | 201k | $89k | -44% | Dec 2024 |
|
| Charles Schwab Investment Management | 187k | $83k | -11% | Dec 2024 |
|
| Renaissance Technologies | 167k | $74k | 100% | Dec 2024 |
|
| Bank of New York Mellon | 161k | $72k | -11% | Dec 2024 |
|
| Barclays | 127k | $56k | 8% | Dec 2024 |
|
| Jane Street | 117k | $52k | 290% | Dec 2024 |
|
| Nuveen Asset Management | 107k | $48k | 0% | Dec 2024 |
|
| a16z Perennial Management | 80k | $35k | 0% | Dec 2024 |
|
| Rhumbline Advisers | 79k | $48k | -17% | Mar 2025 |
|
| SG Americas Securities | 79k | $48k | 60% | Mar 2025 |
|
| Citadel Advisors | 71k | $32k | -89% | Dec 2024 |
|
| Bank of America Corporation | 66k | $29k | -27% | Dec 2024 |
|
| Citigroup | 61k | $20k | 1% | Dec 2024 |
|
| Wells Fargo & Company | 47k | $21k | 28% | Dec 2024 |
|
| Mirae Asset Global Etfs Holdings | 46k | $21k | 4% | Dec 2024 |
|
| Susquehanna International | 45k | $20k | 97% | Dec 2024 |
|
| Corebridge Financial | 39k | $18k | 100% | Dec 2024 |
|
| Millennium Management | 38k | $17k | -90% | Dec 2024 |
|
| Invesco | 38k | $17k | 9% | Dec 2024 |
|
| Bnp Paribas Arbitrage, Snc | 37k | $16k | 100% | Dec 2024 |
|
| Qube Research & Technologies | 32k | $14k | -81% | Dec 2024 |
|
| Virtu Financial | 31k | $14k | 100% | Dec 2024 |
|
| Proficio Capital Partners | 27k | $12k | 0% | Dec 2024 |
|
| Sandia Investment Management | 27k | $12k | 0% | Dec 2024 |
|
| T. Rowe Price Associates | 26k | $12k | 0% | Dec 2024 |
|
| ProShare Advisors | 22k | $9.9k | 49% | Dec 2024 |
|
| Neuberger Berman Group | 22k | $9.6k | 100% | Dec 2024 |
|
| Tower Research Capital | 20k | $8.8k | 127% | Dec 2024 |
|
| AQR Capital Management | 19k | $8.5k | -6% | Dec 2024 |
|
| Dimensional Fund Advisors | 17k | $7.7k | 0% | Dec 2024 |
|
| Beacon Pointe Advisors | 15k | $6.6k | -44% | Dec 2024 |
|
| Royal Bank of Canada | 12k | $0 | 16% | Dec 2024 |
|
| Naples Global Advisors | 10k | $6.1k | 0% | Mar 2025 |
|
| Summit Investment Advisors | 7.8k | $3.4k | 0% | Dec 2024 |
|
| Legal & General Group | 6.9k | $3.1k | 0% | Dec 2024 |
|
| California State Teachers Retirement System | 5.7k | $2.5k | 0% | Dec 2024 |
|
| Picton Mahoney Asset Management | 4.7k | $2.0k | 100% | Dec 2024 |
|
| Simplex Trading | 4.4k | $1.0k | 353% | Dec 2024 |
|
| New York State Common Retirement Fund | 4.0k | $2.0k | 0% | Dec 2024 |
|
| Group One Trading | 3.7k | $1.6k | 100% | Dec 2024 |
|
| Amalgamated Bank | 2.7k | $999.913600 | 0% | Dec 2024 |
|
| Sterling Capital Management | 2.7k | $1.2k | 969% | Dec 2024 |
|
| NISA Investment Advisors | 1.5k | $680.022200 | 499% | Dec 2024 |
|
| SBI Securities | 1.4k | $638.950200 | 100% | Dec 2024 |
|
| Advisor Group Holdings | 1.3k | $1.3k | 0% | Dec 2024 |
|
| CWM | 833.00 | $0 | 32% | Dec 2024 |
|
| Parallel Advisors | 496.00 | $299.980800 | 0% | Mar 2025 |
|
| New Wave Wealth Advisors | 300.00 | $132.990000 | 100% | Dec 2024 |
|
| EverSource Wealth Advisors | 71.00 | $30.998600 | 100% | Dec 2024 |
|
| Pnc Financial Services | 7.00 | $3.000200 | 100% | Dec 2024 |
|
| IFP Advisors | 7.00 | $3.000200 | 100% | Dec 2024 |
|
| Farther Finance Advisors | 1.00 | $1.000000 | 0% | Mar 2025 |
|
Who sold out of Adagio Therapeutics?
Fund or Company Name |
Date Sold |
Shares Held |
Valued At |
|---|---|---|---|
| Slate Path Capital | Sep 2024 | 3.7M | $3.8M |
| Jacobs Levy Equity Management | Sep 2024 | 547k | $558k |
| Marshall Wace | Sep 2024 | 120k | $123k |
| Graham Capital Management | Sep 2024 | 24k | $24k |
| Ing Investment Management | Sep 2024 | 11k | $11k |
| Modus Advisors | Sep 2024 | 11k | $11k |
| JustInvest | Sep 2024 | 11k | $11k |
| Hsbc Holdings | Sep 2024 | 10k | $10k |
| Claris Advisors, Llc / Mo / | Sep 2024 | 500.00 | $510.000000 |
| Aspire Private Capital | Sep 2024 | 200.00 | $204.000000 |
| Allspring Global Investments Holdings | Sep 2024 | 157.00 | $159.998700 |
| Capital Performance Advisors | Sep 2024 | 85.00 | $86.997500 |